New Resource for Patients With a Chronic Widespread Pain Condition
People who think they may have fibromyalgia should know that they are not alone. A new Web site, www.FibroCenter.com, has been designed as a community of education, support and understanding for people with fibromyalgia. The site provides information to help people with their painful symptoms and the impact on their daily lives. It also directs people to helpful resources and encourages them to share their stories.
According to the American College of Rheumatology, fibromyalgia affects at least one in 50 Americans. So, why does "fibromyalgia" remain an unfamiliar term?
Experts think there are changes in the way the brain processes pain. Anyone can develop fibromyalgia at any age, and though the condition mostly affects women, it may also affect men and children as well.
The most common symptom of fibromyalgia is pain all over the body for more than three months. It is common for people to experience morning stiffness and achy muscles that feel tender to the touch. Other symptoms of fibromyalgia can include disturbed sleep, fatigue, mood changes and problems with thinking. Doctors can test to rule out other conditions and determine whether fibromyalgia is the cause of the pain.
There is no cure for fibromyalgia, but symptoms can be managed. A healthy diet, exercise and sufficient sleep may help to ease fibromyalgia symptoms. There is a growing list of treatments that may help, and there is still more work to be done to help the diagnosis and management of fibromyalgia. As scientific knowledge improves, so do the resources available to patients.
The new Web site includes a place for people with fibromyalgia to make a pledge. The pledge asks people to learn about the condition, to seek the best help and to keep a positive attitude. For every visitor who takes the pledge, Pfizer will donate $1 (up to a total of $100,000) to certain organizations that provide fibromyalgia education and support. Specific details can be found at www.FibroCenter.com, which is developed and maintained by Pfizer, Inc.
No comments: